As of 2025-03-16, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 16.9x | 5.7x |
| Forward P/E multiples | 7.2x - 10.7x | 9.0x |
| Fair Price | (12.30) - (18.50) | (12.45) |
| Upside | -898.6% - -1301.0% | -908.5% |
| Date | EV/EBITDA |